DENTI, VANNA
 Distribuzione geografica
Continente #
AS - Asia 6.111
NA - Nord America 6.045
EU - Europa 4.439
SA - Sud America 703
AF - Africa 124
OC - Oceania 31
Totale 17.453
Nazione #
US - Stati Uniti d'America 5.834
IT - Italia 1.766
SG - Singapore 1.764
VN - Vietnam 1.681
CN - Cina 1.154
HK - Hong Kong 619
BR - Brasile 540
DE - Germania 502
RU - Federazione Russa 445
SE - Svezia 302
IE - Irlanda 277
GB - Regno Unito 259
FR - Francia 195
IN - India 190
AT - Austria 138
CA - Canada 135
NL - Olanda 104
KR - Corea 103
BD - Bangladesh 93
ES - Italia 80
JP - Giappone 75
UA - Ucraina 66
FI - Finlandia 65
AR - Argentina 63
ID - Indonesia 63
IQ - Iraq 62
PL - Polonia 59
TR - Turchia 51
ZA - Sudafrica 48
CH - Svizzera 46
MX - Messico 41
PK - Pakistan 39
AU - Australia 31
TW - Taiwan 29
DK - Danimarca 28
EC - Ecuador 25
SA - Arabia Saudita 24
CO - Colombia 23
PH - Filippine 21
BE - Belgio 20
IR - Iran 17
MA - Marocco 17
LT - Lituania 14
VE - Venezuela 14
MY - Malesia 13
UZ - Uzbekistan 13
AE - Emirati Arabi Uniti 11
CL - Cile 11
CZ - Repubblica Ceca 11
IL - Israele 11
AZ - Azerbaigian 10
JO - Giordania 10
TN - Tunisia 10
KE - Kenya 9
PT - Portogallo 9
CR - Costa Rica 8
NO - Norvegia 8
PY - Paraguay 8
TH - Thailandia 8
ET - Etiopia 7
KZ - Kazakistan 7
LB - Libano 7
OM - Oman 7
RO - Romania 7
BO - Bolivia 6
PE - Perù 6
UY - Uruguay 6
HU - Ungheria 5
LV - Lettonia 5
NI - Nicaragua 5
PS - Palestinian Territory 5
SC - Seychelles 5
AL - Albania 4
DZ - Algeria 4
EG - Egitto 4
GR - Grecia 4
HN - Honduras 4
JM - Giamaica 4
PA - Panama 4
RS - Serbia 4
BG - Bulgaria 3
DO - Repubblica Dominicana 3
HR - Croazia 3
KG - Kirghizistan 3
MN - Mongolia 3
NG - Nigeria 3
NP - Nepal 3
SK - Slovacchia (Repubblica Slovacca) 3
AM - Armenia 2
AO - Angola 2
GA - Gabon 2
GE - Georgia 2
KH - Cambogia 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
LY - Libia 2
MT - Malta 2
MU - Mauritius 2
MZ - Mozambico 2
SN - Senegal 2
Totale 17.430
Città #
Singapore 968
Ann Arbor 789
Milan 697
Ashburn 655
San Jose 632
Hong Kong 590
Ho Chi Minh City 505
Hanoi 438
Frankfurt am Main 314
Dallas 292
Dublin 270
Chandler 248
Los Angeles 220
Wilmington 183
New York 179
Beijing 172
Fairfield 163
Santa Clara 142
Hefei 141
Dearborn 113
Chicago 109
Seoul 94
Vienna 92
Houston 91
The Dalles 87
Shanghai 82
Seattle 76
Woodbridge 76
São Paulo 71
Princeton 70
Council Bluffs 61
Da Nang 58
Lauterbourg 58
Orem 57
Buffalo 56
Cambridge 56
Haiphong 51
Rome 50
Kent 48
Moscow 48
Tokyo 47
Helsinki 42
Nanjing 42
Warsaw 40
London 39
Nuremberg 38
Ha Long 37
Montreal 37
Bắc Ninh 36
Jakarta 35
Chennai 34
Munich 34
Denver 32
Toronto 32
Biên Hòa 30
Brooklyn 30
Dong Ket 30
Madison 30
Vũng Tàu 30
Manchester 29
Sesto San Giovanni 29
Ninh Bình 28
Poplar 28
Quận Bình Thạnh 28
Zurich 28
Stockholm 27
Turin 26
Hải Dương 25
Pune 25
Bologna 24
Phoenix 24
Quận Một 24
Thái Nguyên 24
Fremont 22
Guangzhou 22
Amsterdam 21
Baghdad 21
Atlanta 20
Can Tho 20
Basingstoke 19
Busto Arsizio 19
Leiden 19
Cagliari 18
Jacksonville 18
Johannesburg 18
Lissone 18
New Delhi 18
San Francisco 18
Seregno 18
Boston 17
Belo Horizonte 16
Dhaka 16
Naples 16
Paris 16
Brussels 15
Pavia 15
Rio de Janeiro 15
Austin 14
Cantù 14
Lappeenranta 14
Totale 10.623
Nome #
Hyperoxic recovery impacts on metabolic adaptations induced by hypoxic exercise: A lipidomics approach 627
Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging 581
Proteomics of liquid biopsies: Depicting RCC infiltration into the renal vein by MS analysis of urine and plasma 542
In-Depth mapping of the urinary N-glycoproteome: Distinct signatures of ccRCC-related progression 532
Antigen Retrieval and Its Effect on the MALDI-MSI of Lipids in Formalin-Fixed Paraffin-Embedded Tissue 448
Feasibility Study for the MALDI-MSI Analysis of Thyroid Fine Needle Aspiration Biopsies: Evaluating the Morphological and Proteomic Stability Over Time 400
Biallelic PI4KA Mutations Disrupt B-Cell Metabolism and Cause B-Cell Lymphopenia and Hypogammaglobulinemia 389
MALDI-MSI Pilot Study Highlights Glomerular Deposits of Macrophage Migration Inhibitory Factor (MIF) as a Possible Indicator of Response to Therapy in Membranous Nephropathy 386
MiralysTM Ambergen. Sequential MALDI-HiPLEX-IHC and untargeted protein imaging to map the tumour-immune environment: academic researcher experience 371
Picture this: Mass Spectrometry Imaging to unveil the multiomic layers of the tumor immune environment 364
Sequential MALDI-HiPLEX-IHC and Untargeted Spatial Proteomics Mass Spectrometry Imaging to Detect Proteomic Alterations Associated with Tumour Infiltrating Lymphocytes 362
Detecting Proteomic Indicators to Distinguish Diabetic Nephropathy from Hypertensive Nephrosclerosis by Integrating Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging with High-Mass Accuracy Mass Spectrometry 358
Hyperoxic recovery interferes with the metabolic imprint of hypoxic exercise 356
High Spatial Resolution MALDI-MS Imaging in the Study of Membranous Nephropathy 355
Development of multi-omic mass spectrometry imaging approaches to assist clinical investigations 349
Matrix-assisted laser desorption/ionisation mass spectrometry imaging in the study of gastric cancer: A mini review 347
Erratum: Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section (Journal of Proteome Research (2022) 21: 11 (2798−2809) DOI: 10.1021/acs.jproteome.2c00601) 345
The management of haemoglobin interference for the MALDI-MSI proteomics analysis of thyroid fine needle aspiration biopsies 342
Feasibility of MALDI-MSI-Based Proteomics Using Bouin-Fixed Pathology Samples: Untapping the Goldmine of Nephropathology Archives 329
Lipidomic typing of colorectal cancer tissue containing tumour-infiltrating lymphocytes by MALDI mass spectrometry imaging 305
Blood microsampling for untargeted metabolomics: a preliminary study on patients affected by myocardial infarction 286
A molecular imaging approach to individuate tumour infiltrating lymphocytes 279
Spatial lipidomics of tumour-infiltrating lymphocytes for the typing of colorectal cancer by MALDI mass spectrometry imaging 262
Mapping the distribution of bioactive compounds and aroma/flavour precursors in green coffee beans with an integrated mass spectrometry-based approach 252
Lipids, proteins, cells: advanced spatial multiomics to delve deeper into the complex molecular and cellular landscape of the tumour microenvironment 248
Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section 239
Novel frontiers in diagnostic pathology: MALDI-MSI of thyroid fine needle aspiration biopsies 231
Dual Functionalized Liposomes for Selective Delivery of Poorly Soluble Drugs to Inflamed Brain Regions 228
Progress in clinical applications for the proteomics MALDI Imaging analysis of thyroid fine needle aspiration biopsies 223
Advances in clinical proteomics for analysis of fine needle aspiration biopsies: evaluating proteomics stability in preservative solutions 223
Enhancing proteomics characterization of thyroid nodules: a pixel-classifier for mass spectrometry imaging analyses 220
6-Aza-2-Thiothymine as an Alternative Matrix for Spatial Proteomics with MALDI-MSI 217
A Mass Spectrometry Imaging-based multiomics approach to map the tumour-immune landscape of clear cell Renal Cell Carcinoma and gain insights into resistance to immunotherapy 217
What’s brewing? Mapping the distribution of bioactive compounds in green C. arabica coffee beans through MS-driven spatial metabolomics 204
Exploring 6-aza-2-Thiothymine as a MALDI-MSI Matrix for Spatial Lipidomics of Formalin-Fixed Paraffin-Embedded Clinical Samples 201
New insights in lipids MALDI MS imaging in FFPE tissue: Antigen retrieval and its effect on positive ion species 201
Spatially Resolved Molecular Characterization of Noninvasive Follicular Thyroid Neoplasms with Papillary-like Nuclear Features (NIFTPs) Identifies a Distinct Proteomic Signature Associated with RAS-Mutant Lesions 199
Progress in clinical applications for the MALDI-imaging analysis of thyroid fine needle aspiration biopsies: evaluation of proteomic stability in preservative solutions 198
The evolving landscape of diagnostic pathology: a step towards the integration of MALDI-MSI for the routine diagnosis of thyroid fine needle aspiration biopsies 192
Image segmentation with Bayesian mixtures models for multiomics MSI analyses 190
UHPLC-TIMS-PASEF®-MS for Lipidomics: From Theory to Practice 188
Revolutionizing Blood Collection: Innovations, Applications, and the Potential of Microsampling Technologies for Monitoring Metabolites and Lipids 182
Progress in clinical applications for the MALDI-Imaging analysis of thyroid biopsies: evaluation of proteomic stability in preservative solutions 180
Blood microsampling for untargeted metabolomics: a preliminary study on patients affected by myocardial infarction 178
The management of haemoglobin interference for the MALDI-MSI analysis of in-vivo thyroid biopsies 178
MALDI-MSI analysis of lipid alterations in FFPE patient-derived breast cancer xenograft for pre-clinical and clinical application 178
Molecular signatures of medullary thyroid carcinoma by MALDI-MSI 177
MALDI-MS imaging in glomerular kidney diseases: from diagnostics to precision medicine? 177
Delving deeper into the Tumour Microenvironment: a MS-driven spatial multiomics approach to provide new molecular insights into immune-tumour cell communication 176
Paving the path toward multi-omics approaches in the diagnostic challenges faced in thyroid pathology 170
Unraveling autophagic imbalances and therapeutic insights in Mecp2-deficient models 167
Therapeutic induction of energy metabolism reduces neural tissue damage and increases microglia activation in severe spinal cord injury 167
Molecular signatures of medullary thyroid carcinoma by MALDI-MSI 165
The interplay of NAD and hypoxic stress and its relevance for ageing 159
Towards a standardised protocol for proteomic analysis of thyroid fine-needle-aspiration biopsies by MALDI-MSI: Management of haemoglobin interference 158
Tri-modal MALDI-MS imaging on the same tissue section: deeper molecular insights of disease 157
Biomarker identification through spatial proteomics for the characterization of indeterminate thyroid nodules 154
Tri-modal MALDI-MS Imaging: new frontiers in diagnostics 153
Delving deeper into the tissue proteome: improving cell-specificity with high spatial resolution MALDI-MS Imaging 146
High Intensity Concentric-Eccentric Exercise Under Hypoxia Changes the Blood Metabolome of Trained Athletes 144
Tri-modal MALDI-MS imaging of lipids, N-Glycans, and proteins on a single tissue section 144
Reproducible lipid alterations in patient-derived breast cancer xenograft ffpe tissue identified with maldi msi for pre-clinical and clinical application 143
Towards lipid MALDI-MS imaging in FFPE tissue: antigen retrieval and its effect on positive ion species 143
Enhanced Detection of Escherichia coli Lipids and Proteins Using Graphene-Polyglycerol Amine via Mass Spectrometry 139
Advances in thyroglobulin measurement: exploring dried blood spot sampling and mass spectrometry for enhanced clinical utility 133
New frontiers in Pathology: MALDI-MS Imaging for diagnosis of thyroid fine needle aspiration biopsies 126
The impact of hyperoxia and hypoxic interval training on the plasma metabolome in skiing athletes 120
Understanding the metabolic role of trehalose in inducing autophagy 102
Visualization of Small Intact Proteins in Breast Cancer FFPE Tissue 92
Revisiting Thyroglobulin Measurement: Current Methods and Future Perspectives Using Dried Blood Spot Sampling for Enhanced Clinical Practice 77
6-Aza-2-Thiothymine as a Novel Matrix for MALDI-MSI-Based Lipid Profiling in FFPE Samples 73
Improving the Annotation for Spatial Proteomics: A Computational Approach to Enhance Molecular Characterization of Thyroid Nodules 71
The metabolic role of trehalose in autophagy induction in central nervous system 71
Deceiving on central nervous system trehalose activity 69
Co-registration of mass spectrometry and optical whole slide histology images for computational pathology 68
Elaboration Pipeline for the Management of MALDI-MS Imaging Datasets 67
Multi-omic and multimodal characterization of thyroid nodules: novel interplay between molecular and morphological features 66
Towards morpho-molecular learning in computational pathology 64
MMP2-Responsive Liposomes Targeting LDLR Enhance the Effectiveness of Anti-Cancer Drugs in Treating Melanoma 58
Exploring 6-Aza-2-Thiothymine as a MALDI-MSI Matrix for Lipid Mapping in FFPE Samples 47
N-Glycan profiling from DBS using the power of timsTOF fleX 46
Advances in thyroglobulin measurement: exploring dried blood spot mass spectrometry for enhanced clinical utility 38
EXPLORING THE MULTI-OMIC LANDSCAPE OF THYROID NODULES: A RETROSPECTIVE STUDY 37
Totale 17.946
Categoria #
all - tutte 48.265
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.265


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021152 0 0 0 0 0 0 0 0 0 0 50 102
2021/2022738 46 58 35 125 52 72 7 42 31 49 98 123
2022/20231.164 146 258 137 106 43 159 15 76 87 17 61 59
2023/20241.085 47 35 45 82 91 284 208 42 58 25 59 109
2024/20253.115 91 182 143 104 340 155 216 124 382 490 374 514
2025/20269.596 1.607 828 835 1.231 922 415 1.390 470 739 1.040 119 0
Totale 17.946